Pfizer, Research Formulation, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK.
Nat Rev Drug Discov. 2010 Aug;9(8):597-614. doi: 10.1038/nrd3187.
The permeability of biological membranes is one of the most important determinants of the pharmacokinetic processes of a drug. Although it is often accepted that many drug substances are transported across biological membranes by passive transcellular diffusion, a recent hypothesis speculated that carrier-mediated mechanisms might account for the majority of membrane drug transport processes in biological systems. Based on evidence of the physicochemical characteristics and of in vitro and in vivo findings for marketed drugs, as well as results from real-life discovery and development projects, we present the view that both passive transcellular processes and carrier-mediated processes coexist and contribute to drug transport activities across biological membranes.
生物膜的通透性是药物药代动力学过程的最重要决定因素之一。虽然人们通常认为许多药物物质是通过被动跨细胞扩散穿过生物膜运输的,但最近有一个假说推测,载体介导的机制可能解释生物系统中大多数的膜药物转运过程。基于对已上市药物的物理化学特性以及体外和体内研究结果的证据,以及从实际发现和开发项目中获得的结果,我们提出这样的观点,即被动跨细胞过程和载体介导过程共存并共同促进药物穿过生物膜的转运活动。